Submission Details

Molecule(s):
O=C(CCl)Nc1cccc(N2CCCC2=O)c1

LON-WEI-8f408cad-1

O=C(CCl)Nc1cccc(N2CCCC2=O)c1

O=C(CCl)N1CCN(S(=O)(=O)c2c(F)cccc2F)CC1

LON-WEI-8f408cad-2

O=C(CCl)N1CCN(S(=O)(=O)c2c(F)cccc2F)CC1

piperazine-chloroacetamide Enamine Mcule MolPort Assayed View
O=C(CCl)N1CCN(S(=O)(=O)c2cccs2)CC1

LON-WEI-8f408cad-3

O=C(CCl)N1CCN(S(=O)(=O)c2cccs2)CC1

piperazine-chloroacetamide Enamine Mcule MolPort Assayed View
O=C(CCl)N1CCN(S(=O)(=O)c2cccc(F)c2)CC1

LON-WEI-8f408cad-4

O=C(CCl)N1CCN(S(=O)(=O)c2cccc(F)c2)CC1

piperazine-chloroacetamide Enamine Mcule MolPort Assayed View
O=C(CCl)N1CCN(Cc2cccs2)CC1

LON-WEI-8f408cad-5

O=C(CCl)N1CCN(Cc2cccs2)CC1

piperazine-chloroacetamide Enamine Mcule MolPort Assayed View
O=C(CCc1c[nH]nn1)NC(Cn1cccn1)c1ccccc1

LON-WEI-8f408cad-6
Duplicate of:
BAR-COM-4e090d3a-30

O=C(CCc1c[nH]nn1)NC(Cn1cccn1)c1ccccc1

Duplicate Enamine MolPort Assayed View
O=C(CCl)N1CCN(Cc2ccsc2)CC1

LON-WEI-8f408cad-7

O=C(CCl)N1CCN(Cc2ccsc2)CC1

piperazine-chloroacetamide Enamine Mcule MolPort Assayed View
C=CC(=O)N(c1ccc(C(C)(C)C)cc1)C(C(=O)NC(C)(C)C)c1cccnc1

LON-WEI-8f408cad-8

C=CC(=O)N(c1ccc(C(C)(C)C)cc1)C(C(=O)NC(C)(C)C)c1cccnc1

Ugi MolPort Assayed View
C=CC(=O)N(c1ccc(N(C)C)c(C)c1)C(C(=O)NC(C)(C)C)c1cccnc1

LON-WEI-8f408cad-9

C=CC(=O)N(c1ccc(N(C)C)c(C)c1)C(C(=O)NC(C)(C)C)c1cccnc1

Ugi Assayed View
C=CC(=O)N(c1ccc(N(C)C)c(C)c1)C(C(=O)Nc1ccc(OC)cc1)c1cccnc1

LON-WEI-8f408cad-10

C=CC(=O)N(c1ccc(N(C)C)c(C)c1)C(C(=O)Nc1ccc(OC)cc1)c1cccnc1

Ugi Mcule Assayed View
O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1

LON-WEI-8f408cad-11
Duplicate of:
LON-WEI-b8d98729-3

O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1

Duplicate Mcule MolPort Assayed View

Design Rationale:

Included in early rounds for synthesis

Other Notes:

Fragments of use are unknown

Inspired By:
Discussion: